Extract

This is a randomized, double-blind, placebo-controlled, multi-center, sequential cohort study in subjects with congestive heart failure (CHF) and impaired renal function who are on stable furosemide treatment (³ 40 mg daily). A total of 50 subjects will be randomized to each increasing dose level of SLV320 or placebo in a sequential fashion.

Inclusion criteria

• Congestive heart failure

Country

• Argentina
• Belgium
• Czech Republic
• Former Serbia and Montenegro
• Germany
• Poland
• Russian Federation
• South Africa
• Spain
• United States

Links

• ictrp
• nct